CClinicalTrials.gg
CompletedNCT03255902Updated Jul 26, 2019Results posted

Family Routines - Healthy Families

An interventional study of Parenting classes in Diabetes Mellitus, Type 1, sponsored by William Beaumont Hospitals. Completed. Open to participants aged 2 Years to 5 Years. Per ClinicalTrials.gov, last updated 2019-07-26.

Sponsored by William Beaumont Hospitals · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Not applicable
Ages
2 Years to 5 Years
Sex
All
01

Study summary

The purpose of the proposed study, Family Routines - Healthy Families, is to examine the feasibility and acceptability of a parenting/family routine intervention program for parents of young children, ages 2-5, with type 1 diabetes.

Read the detailed description

The intervention in Family Routines - Healthy Families contains an established and effective parent skills training curriculum called "The Incredible Years," uniquely integrated with a newly developed family evening routine component e.g., family dinner time and evening routine, to promote improved metabolic control. The investigator will assess outcomes during and at one week post intervention. Outcome measures will include family routine, specifically the time between the dinner and bedtime glucose check, parent bedtime decision making, and child overnight glucose control. In addition, parental quality of life and receptiveness to the intervention will be assessed.

02

Conditions studied

  • Diabetes Mellitus, Type 1

Keywords

  • Diabetes
03

Who can participate

Ages eligible
2 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Self identification as primary care giver of child that fits following criteria:

    1. Age 2 - 5 years
    2. Diagnosis of Type 1 diabetes
    3. Most recent Hemoglobin A1c (HbA1c) > 8.0
    4. Child a patient of Pediatric Endocrinology, Beaumont Children's Hospital
  2. English fluency

Exclusion criteria

Exclusion Criteria:

  1. Cognitively impaired
  2. Does not meet inclusion criteria
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
7 participants (actual)

Study arms

  • Experimental
    Families attending parenting classes

    Families attended 6 parenting sessions, filled out daily glucose screens, \& questionnaires

    Behavioral: Parenting classes

Interventions

  • BehavioralParenting classes

    Parenting Classes:The Incredible Years curriculum

05

What researchers measure

Primary outcomes

  1. Effect of Intervention on Evening Glucose Control.

    Number of families whose child achieved a decrease overnight between bedtime blood glucose level and morning fasting glucose level following intervention at 6 weeks.

    Time frame: After 6 weeks of classes

Secondary outcomes

  1. Difference Between Child's Pre-intervention and 3 Month Hemoglobin A1c Value

    3-month Hemoglobin A1c value subtracted from pre-intervention Hemoglobin A1c value. Positive numbers indicate an improvement in glucose control with intervention, and negative numbers indicate no improvement in glucose control with intervention.

    Time frame: Pre intervention to 3 months post intervention

06

Results

Posted Jul 26, 2019

Participant flow

Participant flow — Overall Study
MilestoneFamilies Attending Parenting Classes
Started7
Completed5
Not completed2

Outcome measures

PrimaryEffect of Intervention on Evening Glucose Control.

Number of families whose child achieved a decrease overnight between bedtime blood glucose level and morning fasting glucose level following intervention at 6 weeks.

Time frame:
After 6 weeks of classes
Reported as:
Count of participants · Participants
Effect of Intervention on Evening Glucose Control.
ParticipantsFamilies Attending Parenting Classes
Effect of Intervention on Evening Glucose Control.2
SecondaryDifference Between Child's Pre-intervention and 3 Month Hemoglobin A1c Value

3-month Hemoglobin A1c value subtracted from pre-intervention Hemoglobin A1c value. Positive numbers indicate an improvement in glucose control with intervention, and negative numbers indicate no improvement in glucose control with intervention.

Time frame:
Pre intervention to 3 months post intervention
Reported as:
Median · percent of HbA1c
Difference Between Child's Pre-intervention and 3 Month Hemoglobin A1c Value
percent of HbA1cFamilies Attending Parenting Classes
Difference Between Child's Pre-intervention and 3 Month Hemoglobin A1c Value-0.3 (-1.1 to 0.6)

Adverse events

Collected over 6 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Families Attending Parenting Class0/7 (0%)0/7 (0%)0/7 (0%)

Baseline characteristics

7 parents enrolled with children between the ages of 2 to 5 years old, but 2 did not complete.

Age, Categorical
Age, Categorical(Participants)Families Attending Parenting Classes
<=18 years0
Between 18 and 65 years7
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Families Attending Parenting Classes
Female2
Male5
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Families Attending Parenting Classes
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American1
White6
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(Participants)Families Attending Parenting Classes
United States7
07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

  • Protocol and statistical analysis plan · Aug 29, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03255902
Lead sponsor
William Beaumont Hospitals
Collaborators
University of Michigan
Responsible party
Donna Marvicsin (Nurse Practitioner, Pediatric Endocrinology, William Beaumont Hospitals) — Principal investigator
First posted
Aug 21, 2017
Start date
May 24, 2016
Primary completion
Mar 1, 2017
Completion
Jan 17, 2019
Results posted
Jul 26, 2019
Last update
Jul 26, 2019

Study contacts

Donna Marvicsin, PhD
principal investigator · William Beaumont Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion